Tolerability of Rebif® Injection With and Without the Use of Rebiject™Mini in Relapsing-Remitting Multiple Sclerosis Subjects

Clinical trial NCT00292253 · COMPLETED

Trial details

NCT number: NCT00292253
Sponsor: EMD Serono
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Sclerosis, Relapsing-remitting

Start date: 2001-01-01
Primary completion: 2002-12-01
Enrollment: 1883

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.